Magazine Article | October 1, 2020

David Lucchino's Circuitous Route To CEO Of Frequency Therapeutics

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

What do baseball, broadcast journalism, and biotech have in common? All are part of the life and unconventional career journey of David Lucchino, cofounder and CEO of Frequency Therapeutics (NASDAQ: FREQ). It’s a path that bucks conventional wisdom, much like what Frequency is trying to do with its goal to restore hearing loss — something previously considered impossible.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: